MedPath

ketamine combination with propofol, dexmedetomidine or fentanyl for sedation in dressing in burn patients

Not Applicable
Conditions
Health Condition 1: T31- Burns classified according to extent of body surface involvedHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/08/044869
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All ASA 1-2 patients aged >18 years with burn injury having superficial to partial thickness burns scheduled for burn dressing.

Exclusion Criteria

a)Patients with any serious co-morbidities like cardiovascular disease, cerebrovascular disease , intracranial hypertension and respiratory tract infection

b)Sinus bradycardia

c)Deep burns or >50% burns

d)History of substance abuse or dependence like alcohol

e)Patients requiring mechanical ventilation

f)Patients requiring vasopressor support

g)Patients in the initial resuscitation phase

h)Difficult airway

i)History of serious adverse effects related to anaesthesia drugs like allergy

j)Pregnancy

k)History of seizures

l)History of any neuropsychiatric disorder

m)Patients on study drug infusion in last 12 hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the sedative and analgesic effects of Ketofol, Ketodex and Ketofen for dressing in burn patients by evaluating <br/ ><br>1.NRS pain scores <br/ ><br>2.Ramsay sedation score <br/ ><br>Timepoint: at the time of dressing
Secondary Outcome Measures
NameTimeMethod
To evaluate the effect of Ketofol , Ketodex and Ketofen on <br/ ><br>1.Hemodynamic profile (HR ,SBP , DBP ,MAP, Spo2, RR) <br/ ><br>2.Satisfaction of the patient <br/ ><br>3.Ease of dressing <br/ ><br>4.Any adverse effects <br/ ><br>Timepoint: at the time of dressing
© Copyright 2025. All Rights Reserved by MedPath